Class Action by Status
Class Action Listing
Pfizer Lipitor (antitrust violations) »
Defendant: Pfizer
Pharmaceutical giant Pfizer agreed to pay $35 million to settle allegations that it unlawfully prevented generic versions of Lipitor, a drug prescribed to lower cholesterol, off the market, resulting in buyers paying more for the medication. If you purchased Lipitor in any one of two dozen states or Washington, Claim deadline is Friday, 29 November 2024.
Pfizer Lipitor (antitrust violations) »
Defendant: Pfizer
Pharmaceutical giant Pfizer agreed to pay $35 million to settle allegations that it unlawfully prevented generic versions of Lipitor, a drug prescribed to lower cholesterol, off the market, resulting in buyers paying more for the medication. If you purchased Lipitor in any one of two dozen states or Washington, D.C., without the use of a Pfizer co-pay card, between June 28, 2011, and Nov. 29, 2011, or you purchased the generic atorvastatin calcium these locations between Nov. 30, 2011, and Dec. 31, 2012, you may be eligible for payment.
Claim deadline is Friday, 29 November 2024.
×